Amalgamated Bank Trims Position in Herbalife Ltd. (NYSE:HLF)

Amalgamated Bank cut its position in shares of Herbalife Ltd. (NYSE:HLFFree Report) by 7.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,583 shares of the company’s stock after selling 998 shares during the quarter. Amalgamated Bank’s holdings in Herbalife were worth $192,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in HLF. Iridian Asset Management LLC CT boosted its position in shares of Herbalife by 49.1% during the fourth quarter. Iridian Asset Management LLC CT now owns 1,468,636 shares of the company’s stock valued at $22,411,000 after purchasing an additional 483,635 shares in the last quarter. Federated Hermes Inc. boosted its position in shares of Herbalife by 6,949,960.0% during the third quarter. Federated Hermes Inc. now owns 347,503 shares of the company’s stock valued at $4,862,000 after purchasing an additional 347,498 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Herbalife by 265.9% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 366,262 shares of the company’s stock valued at $5,124,000 after purchasing an additional 266,166 shares in the last quarter. UBS Group AG boosted its position in shares of Herbalife by 5.6% during the third quarter. UBS Group AG now owns 3,989,128 shares of the company’s stock valued at $55,808,000 after purchasing an additional 209,949 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Herbalife by 9.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,742,507 shares of the company’s stock valued at $24,378,000 after purchasing an additional 147,003 shares in the last quarter.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on HLF shares. Mizuho dropped their price target on Herbalife from $12.00 to $10.00 and set a “neutral” rating on the stock in a research report on Thursday, March 21st. DA Davidson reissued a “neutral” rating and issued a $9.50 target price on shares of Herbalife in a report on Thursday, May 2nd. Bank of America dropped their target price on Herbalife from $10.00 to $8.00 and set an “underperform” rating on the stock in a report on Thursday, March 21st. Finally, StockNews.com downgraded Herbalife from a “buy” rating to a “hold” rating in a report on Friday, May 17th. One research analyst has rated the stock with a sell rating and five have given a hold rating to the company’s stock. According to MarketBeat, Herbalife has a consensus rating of “Hold” and an average target price of $10.50.

Get Our Latest Stock Analysis on HLF

Herbalife Price Performance

HLF stock opened at $11.28 on Thursday. Herbalife Ltd. has a 1-year low of $6.68 and a 1-year high of $19.48. The business has a fifty day moving average price of $9.29 and a 200-day moving average price of $11.24. The stock has a market capitalization of $1.13 billion, a P/E ratio of 8.23 and a beta of 1.24.

Herbalife (NYSE:HLFGet Free Report) last posted its quarterly earnings results on Wednesday, May 1st. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.12. Herbalife had a negative return on equity of 19.97% and a net margin of 2.70%. The firm had revenue of $1.30 billion during the quarter, compared to analysts’ expectations of $1.26 billion. During the same quarter in the previous year, the business earned $0.54 earnings per share. The company’s revenue was up 3.8% on a year-over-year basis. As a group, analysts anticipate that Herbalife Ltd. will post 1.48 earnings per share for the current year.

Insider Transactions at Herbalife

In other Herbalife news, Director Juan Miguel Mendoza purchased 7,000 shares of the firm’s stock in a transaction dated Friday, May 10th. The stock was purchased at an average price of $10.65 per share, for a total transaction of $74,550.00. Following the completion of the purchase, the director now directly owns 93,279 shares of the company’s stock, valued at $993,421.35. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, Director Juan Miguel Mendoza acquired 7,000 shares of Herbalife stock in a transaction that occurred on Friday, May 10th. The stock was bought at an average price of $10.65 per share, for a total transaction of $74,550.00. Following the completion of the transaction, the director now owns 93,279 shares in the company, valued at $993,421.35. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Henry C. Wang acquired 2,778 shares of Herbalife stock in a transaction that occurred on Tuesday, March 26th. The shares were purchased at an average price of $9.30 per share, with a total value of $25,835.40. Following the transaction, the executive vice president now owns 176,194 shares of the company’s stock, valued at approximately $1,638,604.20. The disclosure for this purchase can be found here. Insiders acquired 66,532 shares of company stock worth $643,642 over the last quarter. 0.94% of the stock is currently owned by insiders.

Herbalife Company Profile

(Free Report)

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.

Further Reading

Institutional Ownership by Quarter for Herbalife (NYSE:HLF)

Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.